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Focal splenic masses are encountered in routine clinical practice 
and pose a diagnostic dilemma. A splenic lesion may be discov-
ered incidentally on imaging studies performed for other diseases. 
Malignant solid splenic lesions include leukemic infiltrates, lym-
phoma, metastases and rarely, angiosarcoma [1-4].
Moritz Kaposi first described Kaposi sarcoma (KS) in 1872 [5]. 
Clinically, KS forms dark blue or purplish macular lesions or 
spindle shaped nodular lesions that occur in the skin, lymphoid, 
respiratory and gastrointestinal tissues, in networks of  spindle 
shaped cells and in vascular spaces surrounded by an endothelial 
cell layer on histological imaging [6]. KS occurs most frequently 
in mucocutaneous sites, typically the skin of  the lower extremities, 
face, trunk, genitalia and oropharyngeal mucosa. KS also com-
monly involves lymph nodes and visceral organs, most notably 
the respiratory and gastrointestinal tracts [7]. But splenic involve-
ment of  KS is very infrequent and is clinically unexpected [8]. 
The diagnostic approach to splenic involvement of  KS is difficult 
because most procedures have a poor diagnostic yield.
The role of  F-18 fluorodeoxyglucose positron emission tomogra-
phy/computed tomography (FDG PET/CT) in oncological im-
aging is well established. It has high sensitivity and specificity for 
many malignancies [9-12] and may help reveal unexpected sites of  
KS, because of  its ability to scan the whole body. The literature 
regarding the role of  F-18 FDG PET/CT imaging for the evalua-
tion of  visceral and lymphatic involvement and staging in various 
types of  KS are scant [13, 14].
We report the detection of  KS in spleen using F-18 FDG PET/
CT in a human immunodeficiency virus (HIV)-negative patient.
Case Report
A 48-year-old male was seen in June 2011 because of  anemia, 
dyspnea, abdominal discomfort and jaundice. His complete blood 
count on admission was as follows: white blood cell 10000/μL, 
hemoglobin 8.0 g/dL and platelet 18600/μL. The result of  liver 
function tests were elevation of  glutamic oxaloactic transami-
nase, glutamic pyruvate transaminase, bilirubin and depression 
of  serum protein and albumin. Contrast-enhanced abdominal 
CT scan showed a 4.0 cm sized mass lesion in the spleen with 
mild enhancement. F-18 FDG PET/CT was performed to search 
for other malignant diseases. Mass lesion displayed FDG uptake 
with maximum standardized uptake value (SUVmax) 7.0 (Figure 
1). For diagnosis, ultrasonography guided biopsy was performed. 
The section showed vascular channels filled red blood cells and 
infiltration of  atypical spindle and epitheloid cells with angioma-
tous proliferation of  vessel. On immunohistochemical investiga-
tion, 100% immunoreactivity for CD31 was found which sup-
ported the final diagnosis. These findings were consistent with KS 
(Figure 2). The patient was HIV-negative using a macro-enzyme 
immunoassay.
Discussion
KS can be classified into different clinical and epidemiological 
forms. The indolent form of  KS is frequently observed in elderly 
male patients of  Mediterranean or Eastern Europe origin, usually 
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affecting the lower extremities and rarely involving visceral organ 
[15]. The mild form is also observed in organ-transplant recipients 
and patients treated with immunosuppressive therapy for various 
medical conditions [16]. The endemic and aggressive form involv-
ing visceral and lymphatic organs is observed in young adults and 
children of  sub-equatorial Africa [17]. The most aggressive form 
is observed in HIV-positive patients, especially homosexual or bi-
sexual men, where it is generalized and disseminated localizing in 
skin and visceral organs including the gastrointestinal tract and 
lung [18]. Occurrence of  HIV-negative KS is rare and has to be 
distinguished from AIDS associated KS [19]. The prevalence rate 
of  HIV-negative KS varies according to personal factors such as 
race, sex, age and immune status of  the patient. Jakob et al re-
ported that only 20 cases of  HIV-negative KS in German patient 
between 1987 and 2009 and concluded that HIV-negative KS is 
a localized process that rarely involves lymph nodes or organs, 
and is mostly seen in older males from Mediterranean or Eastern 
European countries and is responsive on local or systemic thera-
peutic strategies [19]. The incidence of  HIV-negative KS in East 
Asia including Korea is unknown.
In normal individuals, F-18 FDG uptake in the spleen is less than 
that in the liver and splenic uptake greater than hepatic uptake is 
considered abnormal [20]. F-18 FDG PET/CT has a very high 
sensitivity (92%-100%) for detecting splenic disease in lymphoma 
[21] and is effective in detecting clinically occult KS lesions that 
are difficult to diagnose with standard imaging techniques in more 
advanced stages of  KS [22]. So the technique is useful in distin-
guishing KS as a malignant lesion and can correctly localize the 
appropriate site for biopsy [23]. In our case, F-18 FDG PET/CT 
detected the rare occurrence of  splenic KS, which was confirmed 
by biopsy. 
In summary, this case reports a splenic KS that was detected 
early using F-18 FDG PET/CT in a HIV-negative patient. F-18 
FDG PET/CT may be instrumental in establishing a diagnosis 
of  splenic KS.
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